Genomenon’s unique blend of AI technology and expert scientific review delivers deep genomic insights into genetic drivers of rare diseases and cancer. SAN ANTONIO, May 8, 2023 /PRNewswire/ — Frost & Sullivan today announced that it has awarded Genomenon with the 2023 Global Technology…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.